This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports


The combined company will provide lots of opportunities.

FB, AMZN, NFLX, GOOGL: Jim Cramer's Views

Jim Cramer shares his views on buying FANG and an unexpected turn. Facebook,, Netflix and Alphabet are among the stocks discussed here.

DAL, SAVE, KSS, JCP: Jim Cramer's Views
DAL, SAVE, KSS, JCP: Jim Cramer's Views

11/23/15 - 01:00 AM EST

Jim Cramer shares his views on Nordstrom's quarter and apparel woes. Nordstrom, Delta, Spirit and J.C. Penney are among the stocks discussed here.

A Retail Retrenchment; Playing the Home Improvement Boom: Jim Cramer's Best Blogs

Catch up on Jim Cramer's ideas from this past week, when he wrote about where consumers are spending now, and less obvious ways to profit from robust home improvement sales.

Weekly Roundup
Weekly Roundup
Weekly Roundup (Action Alerts PLUS $)

11/20/15 - 04:51 PM EST

We added to one portfolio position this week as the market made a nice rebound.

Jim Cramer Says Buy Allergan Over Pfizer and Predicts Google Is Headed to $800

Jim Cramer, portfolio manager of the TheStreet's Action Alerts PLUS, said based on valuation investors should buy Allergan over Pfizer.

Jim Cramer Is Watching GameStop's Q3 Earnings Results Monday

TheStreet's Jim Cramer is keeping an eye on GameStop (GME) Monday when the retailer releases it third quarter earnings results before the opening bell.

Jim Cramer Says Google Is Going to $800, Buy Allergan Over Pfizer

TheStreet's Jim Cramer says based on valuation, investors should buy Allergan (AGN) over Pfizer (PFE) because the two are moving closer to an acquisition.

The Allergan-Pfizer Deal Has a Green Light

The Treasury Department's updated rules do not affect it.

Allergan-Pfizer Talks Still Moving Apace

The latest update demonstrates the companies' commitment to the deal despite concerns over Jack Lew's recent statements.

Page 2 of 1659
Top Rated Stocks Top Rated Funds Top Rated ETFs